Pathophysiology and treatment of aplastic anemia

Wiener Klinische Wochenschrift

Volumn 115, Issue 13-14, 2003, Pages 444-450

  Geissler, Klaus ^a  

^a GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Aplastic anemia; Pathophysiology; Treatment

Indexed keywords

ANDROGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 3; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; AUTOIMMUNITY; BONE MARROW DISEASE; BONE MARROW SUPPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOLID TUMOR;

EID: 0042319309     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03041027     Document Type: Review

References (71)

1. Ehrlich P (1888) Über eine Fall von Anämie mit Bemerkungen über regenerative Veränderungen des Knochenmarkes. Charite Ann 13: 300
2. Chauffard M (1904) Un cas d'anemie pernicieuse aplastique. Bull Mem Soc Med Hop Paris 21: 313
3. International Agranulocytosis and Aplastic Anemia Study (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 70: 1718-1721
4. Szklo M, Sensenbrenner L, Markowitz J, Weida S, Warm S, Linet M (1985) Incidence of aplastic anemia in metropolitan Baltimore: a population-based study. Blood 66: 115-119
5. Young NS, Issaragrasil S, Chieh CW, Takaku F (1986) Aplastic anaemia in the Orient. Br J Haematol 62: 1-6
6. Yamashita T, Nakahata T (2001) Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. Int J Hematol 74: 33-41
7. Rathbun RK, Faulkner GR, Ostroski MH, Christianson TA, Hughes G, Jones G, Cahn R, Maziarz R, Royle G, Keeble W, Heinrich MC, Grompe M, Tower PA, Bagby GC (1997) Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 90: 974-985
8. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413: 432-435
9. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, Ball S, Tchernia G, Klar J, Matsson H, Tentler D, Mohandas N, Carlsson B, Dahl N (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21: 169-175
10. Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M (2000) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317-2322
11. Heaney ML, Golde DW (1999) Myelodysplasia. N Engl J Med 340: 1649-1660
12. Biesma DH, van den Tweel JG, Verdonck LF (1997) Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 79: 1548-1551
13. Kinoshita T, Inoue N, Takeda J (1996) Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. Annu Rev Med 47: 1-10
14. Young NS, Maciejewski J (1997) Mechanisms of disease. The pathophysiology of acquired aplastic anemia. N Engl J Med 336: 1365-1372
15. Maciejewski JP, Anderson S, Katevas P, Young NS (1994) Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 87: 227-234
16. Scopes J, Bagnara M, Gordon-Smith EC, Ball SE, Gibson FM (1994) Haemopoietic progenitor cells are reduced in aplastic anaemia. Br J Haematol 86: 427-430
17. Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP (1997) Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 126: 116-122
18. Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85: 3058-3065
19. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H for the German Aplastic Anemia Study Group (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324: 1297-1304
20. Hoffmann R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR (1977) Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med 296: 10-13
21. Ascensao J, Pahwa R, Kagan W, Hansen J, Moore M, Good RA (1976) Aplastic anemia: evidence for an immunological mechanism. Lancet 1: 669-671
22. Kagan WA, Ascensao JA, Pahwa RN, Hansen JA, Goldstein G, Valera EB, Incefy GS, Moore MAS, Good RA (1976) Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. Proc Natl Acad Sci USA 73: 2890-2894
23. Haak HL, Goselink HM (1977) Mechanism in aplastic anemia. Lancet 1: 194
24. Singer JW, Doney KC, Thomas ED (1979) Coculture studies of 16 untransfused patients with aplastic anemia. Blood 54: 180-185
25. Takaku F, Suda T, Mizoguchi H, Miura Y, Uchino H, Nagai K, Kariyone S, Shibata A, Akabane T, Nomura T, Maekawa T (1980) Effect of peripheral blood mononuclear cells from aplastic anemia patients on the granulocyte-macrophage and erythroid colony formation in samples from normal human bone marrow in vitro - a cooperative work. Blood 55: 937-944
26. Geissler K, Kabrna E, Kollars M, Ohler L, Berer A, Burgmann H, Winkler S, Willheim M, Hinterberger W, Lechner K (2002) Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia. Hematol J 3: 206-213
27. Singer JW, Brown JE, Storb R, Thomas ED (1978) Effect of peripheral blood lymphocytes from patients with aplastic anemia on granulocytic colony growth from HLA-matched and -mismatched marrows: effect of transfusion sensitization. Blood 52: 37-46
28. Torok-Storb BJ, Sieff C, Storb R, Adamson J, Thomas ED (1980) In vitro tests for distinguishing possible immune-mediated aplastic anemia from transfusion-induced sensitization. Blood 55: 211-215
29. Hinterberger W, Adolf G, Bettelheim P, Geissler K, Huber C, Irschick E, Kalhs P, Köller U, Lechner K, Meister B, Woloszczuk W (1989) Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood 74: 2713-2717
30. Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82: 188-192
31. Tong J, Bacigalupo A, Piaggio G, Figari O, Sogno G, Marmont A (1991) In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin. colony-stimulating activity and lymphokine production. Exp Hematol 19: 312-316
32. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Höcker P, Huber C, Kalhs P, Knapp W, Köller U, Lechner K, Volc-Platzer B (1988) Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72: 266-272
33. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY (1983) Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131: 1300-1305
34. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffmann R, Rubin BY (1986) The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J Immunol 136: 4487-4495
35. Selleri C, Sato T, Anderson S. Young NS, Maciejewski JP (1995) Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165: 538-546
36. Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T (1992) Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79: 2532-2535
37. Nistico A, Young NS (1994) γ-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120: 463-469
38. Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS (1985) Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312: 257-265
39. Maciejewski JP, Selleri C, Anderson S, Young NS (1995) Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85: 3183-3190
40. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS (1995) Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 91: 245-252
41. Philpott NJ, Scopes J, Marsh JCW, Gordon-Smith EC, Gibson FM (1995) Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp Hematol 23: 1642-1648
42. Maciejewski JP, Anderson S, Katevas P, Young NS (1994) Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 87: 227-234
43. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS (1997) Hepatitis-associated aplastic anemia. N Engl J Med 336: 1059-1064
44. Kaufmann DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia. Vol 18 of Monographs in epidemiology and biostatistics. Oxford University Press, New York
45. Issaragrisil S, Chansung K, Kaufman DW, Sirijirachai J, Thamprasit T, Young NS (1997) Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group. Am J Public Health 87: 1551-1554
46. Issaragrisil S, Kaufman DW, Young NS (1995) The epidemiology of acquired aplastic anemia in Thailand. Blood 86 [Suppl 1]: 478a (abstract)
47. Bacigalupo A (1996) Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group. Eur J Haematol [Suppl] 60: 16-19
48. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63-70
49. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, et al (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68: 119-125
50. Hinterberger W, Gadner H, Hocker P, Hajek-Rosenmayr A, Graninger W, Grabner G, Volc-Platzer B, Hawliczek R, Karcher KH, Kallinger W, et al (1987) Survival and quality of life in 23 patients with severe aplastic anemia treated with bone marrow transplantation (BMT). Blut 54: 137-146
51. Hinterberger W (1991) Severe aplastic anemia. Wien Med Wochenschr Heft 9/10: 205-208
52. Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP, Sanders J, Sullivan KM (1998) Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 91: 3637-3645
53. Mathe G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M, Hayat M, Schlumberger JR, Jasmin C (1970) Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 2: 131-136
54. Hinterberger-Fischer M, Hinterberger W, Hockern P, Schmidmeier W, Gadner H, Geissler K, Kos M, Schwarzinger I, Neumann E, Niessner H, et al (1986) Treatment of severe aplastic anemia with combined immunosuppression (antithymocyte globulin and high-dose methylprednisolone). Acta Haematol 76: 196-201
55. Marsh JC, Hows JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC (1987) Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood 70: 1046-1052
56. Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308: 113-118
57. Camitta B, O'Reilly RJ, Sensenbrenner L, Rappeport J, Champlin R, Doney K, August C, Hoffmann RG, Kirkpatrick D, Stuart R, Santos G, Parkman R, Gale RP, Storb R, Nathan D (1983) Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 62: 883-888
58. Stryckmans PA, Dumont JP, Velu T, Debusscher L (1984) Cyclosporine in refractory severe aplastic anemia. N Engl J Med 310: 655-656
59. Meidlinger P, Knobl P, Jager U, Gisslinger H, Pabinger I, Weltermann A, Lechner K, Geissler K (1999) Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment. Ann Hematol 78: 299-304
60. Hinterberger-Fischer M, Hocker P, Lechner K, Seewann H, Hinterberger W (1989) Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Haematol 43: 136-142
61. de Planque MM, Brand A, Kluin-Nelemans HC, Eernisse JG, van der Burgh F, Natarajan AT, Beverstock GC, Zwaan FE, Willemze R, van Rood JJ (1989) Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti-thymocyte globulin. Br J Haematol 71: 421-430
62. Tichelli A, Gratwohl A, Nissen C, Speck B (1994) Late clonal complications in severe aplastic anaemia. Leukemia and Lymphoma 12: 167-175
63. Shahidi NT, Diamond KL (1959) Testosterone-induced remission in aplastic anemia. Am J Dis Child 98: 293
64. Li FP, Alter BP, Nathan DG (1972) The mortality of acquired aplastic anemia in children. Blood 40: 153-162
65. Champlin RE, Ho WG, Feig SA, Winston DJ, Lenarsky C, Gale RP (1985) Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood 66: 184-188
66. Locasciulli A, Porta F, Vossen JM, Bacigalupo A (1989) Treatment of acquired severe aplastic anemia (SAA) in children: an analysis of the EBMT-SAA working party. Bone Marrow Transplant 4 [Suppl 2]: 90
67. Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ (2001) Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 135: 477-483
68. Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, Barrett AJ, Walsh TJ, Rosenfeld SJ, Young NS (2000) High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 356: 1554-1559
69. Kojima S (1996) Use of hematopoietic growth factors treatment of aplastic anemia. Bone Marrow Transplant 18 [Suppl 3]: 36-38
70. Geissler K, Forstinger C, Kalhs P, Knobl P, Kier P, Kyrle P, Lechner K (1992) Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia. Ann Intern Med 117: 223-225
71. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, et al (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85: 1348-1353